文献速递肝病

肝移植后衰弱、死亡与医疗资源利用:来自多中心肝移植功能评估(FrAILT)研究

Frailty, mortality, and health care utilization after liver transplantation: From the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study.
PubMed 文献 · Hepatology · 2021-12-29

该多中心队列纳入美国8个中心2012至2019年的1166例成人肝移植受者,用肝衰弱指数(LFI)在门诊评估移植前衰弱(LFI≥4.5为衰弱)。移植前衰弱与移植后死亡风险升高及住院时间、ICU天数、90天内住院日和非家庭出院 odds 升高相关,但总体移植后生存可接受。

要点

  • 移植前衰弱(LFI≥4.5)者占21%,其移植后1年和5年死亡累积发生率分别为6%和16%,非衰弱者为4%和10%(整体log-rank p=0.02)。
  • 校正BMI、HCC、供者年龄和心脏死亡后捐献状态后,移植前衰弱与移植后死亡风险升高相关(HR 2.13,95%CI 1.39-3.26)。
  • 衰弱者移植后延长住院、ICU停留、90天内住院日及非家庭出院的校正OR分别为2.00、1.56、1.72和2.50。

核心结论

  • 与非衰弱患者相比,衰弱肝移植受者移植后死亡风险更高、医疗资源利用更多,但总体移植后生存可接受。
  • 这些数据为研究针对移植前衰弱能否改善移植后结局并减少资源利用奠定基础。

研究设计与样本

  • 多中心队列研究,纳入美国8个中心2012至2019年的成人肝移植受者。
  • 移植前衰弱在门诊用肝衰弱指数(LFI)评估,衰弱定义为LFI≥4.5。
  • 延长移植后住院时间定义为≥12天,延长ICU天数定义为≥4天,延长移植后90天内住院日定义为≥17天,均采用第75百分位数。

主要发现

  • 1166例肝移植受者中21%移植前衰弱。
  • 衰弱者移植后1年和5年死亡累积发生率分别为6%和16%,非衰弱者分别为4%和10%(整体log-rank p=0.02)。
  • 移植前衰弱与未校正的移植后死亡风险增加62%相关(95%CI 1.08-2.44)。
  • 校正BMI、HCC、供者年龄和心脏死亡后捐献状态后,移植前衰弱与移植后死亡风险升高相关(HR 2.13,95%CI 1.39-3.26)。
  • 衰弱者与非衰弱者相比,延长移植后住院时间(OR 2.00,95%CI 1.47-2.73)、延长ICU停留(OR 1.56,95%CI 1.12-2.14)、延长移植后90天内住院日(OR 1.72,95%CI 1.25-2.37)和非家庭出院(OR 2.50,95%CI 1.58-3.97)的校正OR更高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Frailty is a well-established risk factor for poor outcomes in patients with cirrhosis awaiting liver transplantation (LT), but whether it predicts outcomes among those who have undergone LT is unknown. APPROACH AND RESULTS: Adult LT recipients from 8 US centers (2012-2019) were included. Pre-LT frailty was assessed in the ambulatory setting using the Liver Frailty Index (LFI). "Frail" was defined by an optimal cut point of LFI ≥ 4.5. We used the 75th percentile to define "prolonged" post-LT length of stay (LOS; ≥12 days), intensive care unit (ICU) days (≥4 days), and inpatient days within 90 post-LT days (≥17 days). Of 1166 LT recipients, 21% were frail pre-LT. Cumulative incidence of death at 1 and 5 years was 6% and 16% for frail and 4% and 10% for nonfrail patients (overall log-rank p = 0.02). Pre-LT frailty was associated with an unadjusted 62% increased risk of post-LT mortality (95% CI, 1.08-2.44); after adjustment for body mass index, HCC, donor age, and donation after cardiac death status, the HR was 2.13 (95% CI, 1.39-3.26). Patients who were frail versus nonfrail experienced a higher adjusted odds of prolonged LT LOS (OR, 2.00; 95% CI, 1.47-2.73), ICU stay (OR, 1.56; 95% CI, 1.12-2.14), inpatient days within 90 post-LT days (OR, 1.72; 95% CI, 1.25-2.37), and nonhome discharge (OR, 2.50; 95% CI, 1.58-3.97). CONCLUSIONS: Compared with nonfrail patients, frail LT recipients had a higher risk of post-LT death and greater post-LT health care utilization, although overall post-LT survival was acceptable. These data lay the foundation to investigate whether targeting pre-LT frailty will improve post-LT outcomes and reduce resource utilization.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Lai JC, Shui AM, Duarte-Rojo A, et al. Frailty, mortality, and health care utilization after liver transplantation: From the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study. Hepatology. 2021. PMID: 34862808. doi:10.1002/hep.32268

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。